Point-of-care testing of triglycerides: Evaluation of the accutrend triglycerides system

Clinical Chemistry

Volumn 46, Issue 2, 2000, Pages 287-291

  Luley, Claus ^b   Ronquist, Gunnar ^b   Reuter, Wolfgang ^c   Paal, Valerie ^d   Gottschling, Hans Detlev ^e   Westphal, Sabine ^a   King, George L ^f   Bakker, Stephan J L ^g   Heine, Robert J ^g   Hattemer, Andrew ^h  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d ST BONIFATIUS HOSPITAL   (Germany)

^e Central Laboratory   (Germany)

^f JOSLIN DIABETES CENTER   (United States)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL;

ARTICLE; ATHEROSCLEROSIS; HUMAN; HYPERTRIGLYCERIDEMIA; INSTRUMENTATION; LIPID ANALYSIS; PATIENT CARE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0033975398     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.2.287     Document Type: Article

References (11)

1. 1. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.
2. 2. Opara JU, Levine JH. The deadly quartet - the insulin resistance syndrome. South Med J 1997;90:1162-8.
3. 3. Assmann G, Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116:1713-24.
4. 4. Patsch JR, Miesenbock G, Hopferwieser T, Muhlberger V, Knapp E, Dunn JK, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-45.
5. 5. Groot PH, van Stiphout WA, Krauss XH, Jansen H, van Tol A, van Ramshorst, et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-62.
6. 6. Weintraub MS, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. Br Med J 1996;312:936-9.
7. 7. American Diabetes Association. Nutrition recommendation and principles for peoples with diabetes mellitus. Position statement. Diabetes Care 1999;22(Suppl 1):S42-5.
8. 8. Siekmann L. Isotope dilution mass-spectrometry of total glycerol in human serum - a reference method in clinical chemistry. Fresenius Z Anal Chem 1986;324:280-1.
9. 9. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709-20.
10. 10. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:307-10.
11. 11. Stein EA, Myers GL. National Cholesterol Education Program recommendations for triglyceride measurement: executive summary. Clin Chem 1995;41:1421-6.